ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
45 announcements with these filters
Amanta Healthcare successfully commissioned a 10.8 MWp solar plant for captive consumption. The facility became operational on May 30, 2026, aimed at reducing long-term operational costs.
Amanta Healthcare Limited submitted its Annual Secretarial Compliance Report for FY2026. The report by M/s. Kashyap R. Mehta and Partners confirms overall regulatory compliance with SEBI norms.
Amanta Healthcare Limited confirmed zero deviation in utilizing ₹126 Crore raised via its IPO. Funds were deployed towards capital expenditure and general corporate purposes.
Amanta reported FY26 revenue of ₹288cr with 22% EBITDA margins. Strategy focuses on high-margin SteriPort capacity expansion and renewable energy cost savings.
Amanta Healthcare approved a remuneration hike for MD Shri Bhavesh Patel to ₹13.29 Lakh monthly. The revision, effective April 2026, awaits shareholder approval via special resolution.
Amanta Healthcare appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditor for five years. Internal and Cost Auditors were also re-appointed for FY 2026-27.
Amanta Healthcare reported FY26 revenue of ₹287.68 Crore and 42% YoY profit growth. The company is currently executing major capacity expansions to drive sustainable future growth.
Amanta Healthcare reported FY26 revenue of ₹288 Cr (+5% YoY) and PAT of ₹15 Cr (+42% YoY), driven by improved margins and reduced finance costs.
Amanta Healthcare Ltd reported revenue from operations of ₹77 Cr (+6.8% YoY) and net profit of ₹5.5 Cr (-8.3% YoY) for Q4 FY26.
Amanta Healthcare reported a total income of ₹291.05 Crore for FY26. The Board also updated policies for insider trading and whistleblowers.
Amanta Healthcare scheduled a board meeting on May 19, 2026, to approve audited FY26 financial results. Trading window remains closed until May 22.
Amanta Healthcare clarified that promoter Shri Bhavesh Patel acquired an additional 15,500 shares on March 30, 2026. This credit follows a prior acquisition of 13,300 shares, increasing his total holding to 63,26,544 shares (16.29%).
Amanta Healthcare Ltd clarified that promoter Shri Bhavesh Patel's share acquisition was partially rejected due to technical reasons. Only 13,300 shares were credited out of the intended 28,800. Consequently, his post-transaction holding stands at 63,11,044 shares (16.25%). This update corrects the company's previous disclosure dated April 1st, 2026.
Amanta Healthcare Ltd announced the resignation of Shri Vimal Shrimali, AVP – HR & ADMIN and Senior Management Personnel, effective April 16, 2026. He resigned to pursue better opportunities. The company confirmed he will be relieved from his duties at the close of business hours on the same date.
Amanta Healthcare Limited submitted its quarterly compliance certificate for the period ended March 31, 2026. The filing confirms that MUFG Intime India, the company's Registrar and Share Transfer Agent, processed all dematerialisation requests and updated the register of members within prescribed timelines.